May 18, 2022
- A metamodel-based flexible insulin therapy for type 1 diabetes patients subjected to aerobic physical activity
- The Gut Microbiota: Master of Puppets Connecting the Epidemiology of Infectious, Autoimmune, and Metabolic Disease (Full text HTML, PDF)
- Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor (Full text HTML, PDF)
- Diabetes risk loci-associated pathways are shared across metabolic tissues
- Effects of Nursing Diabetes Self-Management Education on Glycemic Control and Self-Care in Type 1 Diabetes: Study Protocol (Full text HTML, PDF)
- Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes (Full text HTML, PDF)
- Autoantibodies against ATP4A are a feature of the abundant autoimmunity that develops in first-degree relatives of patients with type 1 diabetes
- Evidence of Sex Differences in the Endothelin Pathway in Diabetes
- Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden (Full text HTML, PDF)
